Sarissa Capital Management LP Has Boosted Holding in Achillion Pharmaceuticals (ACHN) as Share Value Rose; Grs Advisors Cut American Homes 4 Rent (AMH) Stake by $4.49 Million as Market Valuation Declined

April 20, 2018 - By Marguerite Chambers

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Logo

Grs Advisors Llc decreased its stake in American Homes 4 Rent (AMH) by 31.41% based on its latest 2017Q4 regulatory filing with the SEC. Grs Advisors Llc sold 213,625 shares as the company’s stock declined 10.74% with the market. The institutional investor held 466,477 shares of the real estate investment trusts company at the end of 2017Q4, valued at $10.19 million, down from 680,102 at the end of the previous reported quarter. Grs Advisors Llc who had been investing in American Homes 4 Rent for a number of months, seems to be less bullish one the $6.71B market cap company. The stock decreased 0.53% or $0.105 during the last trading session, reaching $19.705. About 735,726 shares traded. American Homes 4 Rent (NYSE:AMH) has declined 16.06% since April 20, 2017 and is downtrending. It has underperformed by 27.61% the S&P500.

Alex Denner increased its stake in Achillion Pharmaceuticals Inc (ACHN) by 17% based on its latest 2017Q4 regulatory filing with the SEC. Sarissa Capital Management Lp bought 363,200 shares as the company’s stock rose 28.04% while stock markets declined. The hedge fund run by Alex Denner held 2.50 million shares of the health care company at the end of 2017Q4, valued at $7.20M, up from 2.14 million at the end of the previous reported quarter. Sarissa Capital Management Lp who had been investing in Achillion Pharmaceuticals Inc for a number of months, seems to be bullish on the $504.55 million market cap company. The stock increased 0.80% or $0.029 during the last trading session, reaching $3.659. About 328,334 shares traded. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has declined 2.57% since April 20, 2017 and is downtrending. It has underperformed by 14.12% the S&P500.

Analysts await American Homes 4 Rent (NYSE:AMH) to report earnings on May, 3 after the close. They expect $0.27 earnings per share, up 3.85% or $0.01 from last year’s $0.26 per share. AMH’s profit will be $91.90 million for 18.25 P/E if the $0.27 EPS becomes a reality. After $0.26 actual earnings per share reported by American Homes 4 Rent for the previous quarter, Wall Street now forecasts 3.85% EPS growth.

Investors sentiment increased to 1.8 in Q4 2017. Its up 0.49, from 1.31 in 2017Q3. It increased, as 19 investors sold AMH shares while 60 reduced holdings. 36 funds opened positions while 106 raised stakes. 254.23 million shares or 2.02% more from 249.20 million shares in 2017Q3 were reported. Rafferty Asset Limited Company reported 0.02% stake. Credit Suisse Ag holds 506,911 shares or 0.01% of its portfolio. Thrivent Fincl For Lutherans invested 0.01% in American Homes 4 Rent (NYSE:AMH). Price T Rowe Assocs Md invested in 104,906 shares or 0% of the stock. Cbre Clarion Secs Ltd Limited Liability Company reported 0.02% stake. Schroder Mngmt Grp, a Maine-based fund reported 27,667 shares. 532,168 were accumulated by State Common Retirement Fund. Blackrock Incorporated holds 16.55M shares or 0.02% of its portfolio. Sterling Capital Ltd Llc holds 0.02% of its portfolio in American Homes 4 Rent (NYSE:AMH) for 91,000 shares. Aperio Grp Limited Liability Corp owns 39,806 shares or 0% of their US portfolio. Proshare Ltd has 66,282 shares. Teacher Retirement Systems Of Texas has 80,950 shares. Texas-based Hbk Investments Limited Partnership has invested 0.01% in American Homes 4 Rent (NYSE:AMH). Axa holds 1.10 million shares or 0.09% of its portfolio. 1.92M are owned by Fil.

Among 13 analysts covering American Homes 4 Rent (NYSE:AMH), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. American Homes 4 Rent had 29 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was maintained by Mizuho on Friday, November 3 with “Buy”. The firm earned “Market Outperform” rating on Wednesday, March 9 by Wood. The rating was maintained by FBR Capital on Friday, March 24 with “Buy”. The stock of American Homes 4 Rent (NYSE:AMH) has “Buy” rating given on Wednesday, March 28 by Robert W. Baird. The firm has “Neutral” rating by JP Morgan given on Thursday, December 17. JMP Securities initiated the stock with “Mkt Outperform” rating in Tuesday, October 11 report. The firm earned “Outperform” rating on Friday, December 8 by Wood. Mizuho maintained American Homes 4 Rent (NYSE:AMH) on Monday, March 19 with “Buy” rating. The stock has “Buy” rating by Keefe Bruyette & Woods on Friday, February 23. Mizuho initiated American Homes 4 Rent (NYSE:AMH) on Thursday, February 9 with “Neutral” rating.

Among 11 analysts covering Achillion Pharma (NASDAQ:ACHN), 6 have Buy rating, 0 Sell and 5 Hold. Therefore 55% are positive. Achillion Pharma had 27 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Outperform” rating by FBR Capital given on Thursday, September 15. As per Monday, September 11, the company rating was maintained by Robert W. Baird. The firm earned “Market Perform” rating on Wednesday, May 4 by Leerink Swann. The rating was maintained by Maxim Group on Thursday, August 13 with “Buy”. The firm earned “Hold” rating on Friday, February 23 by FBR Capital. FBR Capital initiated the shares of ACHN in report on Wednesday, February 7 with “Hold” rating. The stock of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has “Buy” rating given on Thursday, February 2 by Ladenburg Thalmann. As per Thursday, May 18, the company rating was upgraded by Leerink Swann. Robert W. Baird maintained it with “Hold” rating and $4.0 target in Monday, October 23 report. The rating was initiated by Chardan Capital Markets with “Sell” on Thursday, July 14.

American Homes 4 Rent (NYSE:AMH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: